Most convincing data from preclinical studies show how VDR can modulate the transcriptome in tumor cells, shaping micro RNA expression in a onco-protective way, and how VDR polymorphisms could increase cancer risk [32,33,34]. This evidence concerns the gene VDR and neoplasm.